CNC vs ELV vs CVS Stock Comparison

Centene, Elevance Health and Cvs Health Prices as of Nov 13, 2026 Peers: Industry group
CNC Centene Corp
$71.26 +1.6% 1M +97.5% 1Y
Market cap
$36.77B
P/E
–
Revenue (TTM)
$194.78B
Div. yield
–
Managed Care Healthcare
2 wins
ELV Elevance Health, Inc.
$429.67 +0.4% 1M +30.9% 1Y
Market cap
$96.13B
P/E
18.7x
Revenue (TTM)
$201.83B
Div. yield
–
Managed Care Healthcare
2 wins
CVS CVS HEALTH Corp
$89.33 -1.2% 1M +12.7% 1Y
Market cap
$115.61B
P/E
10.5x
Revenue (TTM)
$420.61B
Div. yield
–
Managed Care Healthcare
7 wins

Head to Head

11 decided of 12

Cvs Health leads on 7 of the 12 questions below (Cvs Health 7, Centene 2, Elevance Health 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCNCELVCVSLeader
Larger companyMarket capitalisation $36.77B $96.13B $115.61B CVS
Cheaper on earningsLower P/E, profitable companies only -5.5x 18.7x 10.5x CVS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 13.1x 14.3x 10.2x CVS
Faster revenue growthRevenue growth, trailing twelve months +19.4% +3.6% +6.7% CNC
More profitableNet margin, trailing twelve months -3.4% 2.5% 2.6% CVS
Better return on capitalReturn on invested capital -19.9% 8.3% 9.7% CVS
Less leveragedLower net debt / EBITDA 0.0x -0.5x 2.3x ELV
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +97.5% +30.9% +12.7% CNC
Better 5-year returnAnnualised price return, 5 years -1.2%/yr -0.3%/yr -1.0%/yr ELV
Less volatileAnnualised volatility, 1 year 46.4% 35.6% 35.1% CVS
Higher overall scoreMean of the five percentile scores vs peers 51/100 68/100 72/100 CVS

Percentile Scorecard

CNCELVCVS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCNCELVCVS
Valuation 92 #3 of 27 81 #6 of 27 100 #1 of 27
Growth 28 #19 of 26 36 #17 of 26 80 #6 of 26
Profitability 36 #17 of 26 72 #8 of 26 84 #5 of 26
Financial Health 36 #17 of 26 68 #9 of 26 24 #20 of 26
Shareholder Returns 65 #7 of 18 82 #4 of 18 71 #6 of 18
Overall 51 68 72
  • CNC ranked among 27 companies in Healthcare Payers and Distributors
  • ELV ranked among 27 companies in Healthcare Payers and Distributors
  • CVS ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCNCELVCVSSPY
1 month +1.6%+0.4%-1.2% -2.0%
3 months +5.6%+7.3%-8.1% -2.8%
6 months +22.3%+9.4%-6.8% +2.0%
Year to date +73.2%+22.6%+12.6% +10.6%
1 year +97.5%+30.9%+12.7% +12.2%
3 years -2.7%-6.9%+30.4% +68.1%
3 years, per year -0.9%-2.4%+9.3% +18.9%
5 years -6.1%-1.7%-5.0% +61.4%
5 years, per year -1.2%-0.3%-1.0% +10.1%
10 years +181.2%+221.4%+19.0% +248.5%
10 years, per year +10.9%+12.4%+1.8% +13.3%

Risk

MeasureCNCELVCVSSPY
Volatility, 1Y 46.4%35.6%35.1% 13.6%
Downside volatility, 1Y 45.1%38.1%38.8% 13.9%
Beta vs S&P 500, 1Y 0.460.29-0.05 1.00
Return / volatility, 1Y 2.100.870.36 0.90
Max drawdown, 5Y -74.1%-51.2%-60.5% -25.4%
From 52-week high -6.2%-3.5%-19.2% -3.2%
52-week high $75.99$445.45$110.55 $779.14
52-week low $31.80$280.74$70.08 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCNCELVCVS
P/E now vs peer median -5.3xmedian 25.2x 18.1xmedian 25.2x 10.4xmedian 25.2x
P/S now vs peer median 0.2xmedian 0.4x 0.5xmedian 0.4x 0.3xmedian 0.4x
EV/EBITDA now vs peer median 0.2xmedian 14.5x 9.6xmedian 14.5x 8.2xmedian 14.5x
P/FCF now vs peer median 8.1xmedian 16.5x 14.3xmedian 16.5x 7.3xmedian 16.5x
P/B now vs peer median 1.7xmedian 2.7x 2.1xmedian 2.7x 1.4xmedian 2.7x
PEG now vs peer median 0.05median 1.72 -7.75median 1.72 1.22median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCNCELVCVS
Revenue $194.78B $201.83B $420.61B
Gross profit $37.08B $53.35B $186.06B
Operating income -$7.62B $7.70B $15.06B
Net income -$6.68B $5.13B $11.09B
Free cash flow $4.32B $6.51B $15.57B
EPS (diluted) $-13.53 $23.62 $8.55
Cash & equivalents $17.89B $10.35B $11.74B
Total debt $17.40B $30.76B $60.68B
Shares (diluted) 493.12M 217.60M 1.29B
Enterprise value -$37.35B -$46.46B $64.37B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCNCELVCVS
P/E -5.3x 18.1x 10.4x
P/FCF 8.1x 14.3x 7.3x
P/Operating cash flow 6.9x 12.2x 6.1x
P/S 0.2x 0.5x 0.3x
P/B 1.7x 2.1x 1.4x
P/Tangible book 2.3x 2.7x 2.0x
EV/EBITDA 0.2x 9.6x 8.2x
EV/EBIT -4.2x 11.4x 10.6x
EV/Revenue 0.2x 0.4x 0.4x
EV/FCF 7.4x 13.5x 10.3x
EV/Operating cash flow 6.3x 11.6x 8.6x
PEG (3Y EPS CAGR) 0.05 -7.75 1.22

Growth

14 metrics
MetricCNCELVCVS
Revenue growth (1Y) 19.4% 3.6% 6.7%
Revenue CAGR (3Y) 10.5% 6.2% 6.5%
Gross profit growth (1Y) -0.8% 4.3% 5.3%
Gross profit CAGR (3Y) 3.9% 5.5% 10.9%
Operating income growth (1Y) -340.1% -9.2% 206.4%
Operating income CAGR (3Y) -98.2% -4.2% 2.4%
Net income growth (1Y) -302.0% -7.4% 2,369%
Net income CAGR (3Y) -96.3% -5.2% 8.6%
EPS growth (1Y) -314.5% -4.5% 2,213%
EPS CAGR (3Y) -104.5% -2.3% 8.5%
Operating cash flow growth (1Y) 3,204% 54.6% 105.4%
Operating cash flow CAGR (3Y) -6.7% -7.2% 9.9%
Free cash flow growth (1Y) 981.8% 72.9% 147.4%
Free cash flow CAGR (3Y) -6.3% -7.6% 11.3%

Profitability

14 metrics
MetricCNCELVCVS
Gross margin 19.0% 26.4% 44.2%
EBITDA margin 84.8% 4.6% 4.7%
Operating margin -3.9% 3.8% 3.6%
Pretax margin -3.5% 3.1% 2.9%
Net margin -3.4% 2.5% 2.6%
FCF margin 2.2% 3.2% 3.7%
Operating cash flow margin 2.6% 3.8% 4.4%
Return on equity -32.5% 11.4% 13.8%
Return on assets -8.4% 4.0% 4.3%
Return on invested capital -19.9% 8.3% 9.7%
Return on capital employed -17.9% 9.6% 9.2%
Asset turnover 2.5x 1.6x 1.6x
Cash conversion (OCF / net income) -0.8x 1.5x 1.7x
Stock comp / revenue 0.1% 0.1% 0.2%

Financial Health

11 metrics
MetricCNCELVCVS
Debt / assets 22.7% 24.1% 23.5%
Debt / equity 0.9x 0.7x 0.8x
Net debt / EBITDA 0.0x -0.5x 2.3x
Debt / FCF 4.0x 4.7x 3.9x
Liabilities / assets 73.9% 65.0% 68.7%
Equity / assets 26.1% 35.0% 31.3%
Interest coverage -11.2x 5.3x 4.9x
Current ratio 1.1x 1.5x 0.9x
Quick ratio 1.0x 1.2x 0.8x
Cash ratio 0.6x 0.8x 0.2x
Altman Z-score 2.80 3.06 2.51

Shareholder Returns

7 metrics
MetricCNCELVCVS
Dividend yield – 1.6% 3.0%
Net buyback yield 1.2% 2.2% -0.4%
Shareholder yield 1.2% 3.8% 2.6%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCNCELVCVS
Forward P/E 13.1xFY2026 14.3xFY2026 10.2xFY2026
EPS, next fiscal year $5.44FY2026 $30.12FY2026 $8.80FY2026
EPS growth, next FY +161.5%FY2026 -0.6%FY2026 +30.4%FY2026
EPS growth, the year after +8.1% +4.2% +1.1%
Revenue, next fiscal year $206.34BFY2026 $211.92BFY2026 $431.16BFY2026
Revenue growth, next FY +5.9%FY2026 +7.3%FY2026 +7.2%FY2026
Revenue growth, the year after -1.2% +0.0% -5.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCNCELVCVS
Held by institutions 97.9% 91.8% 89.1%
Institutions holding 1,001 1,615 2,074
Change in shares held, QoQ +2.1% +1.7% +3.5%
Institutions buying 569 862 1,103
Institutions selling 334 542 733
Buyers to sellers 1.70 1.59 1.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CNCELVCVS
CNC 1.00 0.61 0.32
ELV 0.61 1.00 0.42
CVS 0.32 0.42 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CNC, ELV and CVS?

Cvs Health (CVS) is the largest by market capitalisation: Centene (CNC) $36.77B, Elevance Health (ELV) $96.13B, Cvs Health (CVS) $115.61B.

Which stock is cheaper, CNC, ELV and CVS?

Cvs Health (CVS) trades on the lowest price-to-earnings ratio (Centene (CNC) -5.5x, Elevance Health (ELV) 18.7x, Cvs Health (CVS) 10.5x). On next year's consensus earnings, Cvs Health (CVS) is cheapest (Centene (CNC) 13.1x, Elevance Health (ELV) 14.3x, Cvs Health (CVS) 10.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Centene (CNC) grew revenue fastest over the trailing twelve months: Centene (CNC) +19.4%, Elevance Health (ELV) +3.6%, Cvs Health (CVS) +6.7%.

Which company is more profitable?

Cvs Health (CVS) has the highest net margin (Centene (CNC) -3.4%, Elevance Health (ELV) 2.5%, Cvs Health (CVS) 2.6%). On return on invested capital, Cvs Health (CVS) leads (Centene (CNC) -19.9%, Elevance Health (ELV) 8.3%, Cvs Health (CVS) 9.7%).

Which stock has performed better?

Over the past year Centene (CNC) returned the most: Centene (CNC) +97.5%, Elevance Health (ELV) +30.9%, Cvs Health (CVS) +12.7%. Over five years, Elevance Health (ELV) compounded fastest (Centene (CNC) -1.2%/yr, Elevance Health (ELV) -0.3%/yr, Cvs Health (CVS) -1.0%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Cvs Health (CVS) has been the steadiest (Centene (CNC) 46.4%, Elevance Health (ELV) 35.6%, Cvs Health (CVS) 35.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CNC, ELV and CVS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cvs Health (CVS) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.